John Wielen Acquires 35,000 Shares of Orthocell Limited (ASX:OCC) Stock

Orthocell Limited (ASX:OCC) insider John Wielen bought 35,000 shares of the company’s stock in a transaction on Monday, April 15th. The shares were acquired at an average price of A$0.39 ($0.25) per share, with a total value of A$13,650.00 ($8,806.45).

Orthocell Stock Performance

The company has a debt-to-equity ratio of 34.88, a quick ratio of 5.07 and a current ratio of 4.60.

Orthocell Company Profile

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries.